PE20001086A1 - Procedimiento para la preparacion de pirazolo [4,3-d] pirimidin-7-onas y sus intermedios - Google Patents
Procedimiento para la preparacion de pirazolo [4,3-d] pirimidin-7-onas y sus intermediosInfo
- Publication number
- PE20001086A1 PE20001086A1 PE1999001016A PE00101699A PE20001086A1 PE 20001086 A1 PE20001086 A1 PE 20001086A1 PE 1999001016 A PE1999001016 A PE 1999001016A PE 00101699 A PE00101699 A PE 00101699A PE 20001086 A1 PE20001086 A1 PE 20001086A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- procedure
- preparation
- zor
- methylpiperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE 1-[[3-6,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL)-4-ETOXIFENIL]SULFONIL-4-METILPIPERAZINA O SILDENAFIL (COMPUESTO IA); 1-ETIL-4-{3-[3-ETIL-6,7-DIHIDRO-7-OXO-2-(2-PIRIMIDILMETIL)-2H-PIRAZOLO[4,3-d]PIRIMIDIN-5-IL]-4-PROPOXIFENILSULFONIL}PIPERAZINA (COMPUESTO IB); QUE COMPRENDE HACER REACCIONAR UN COMPUESTO DE FORMULA (IIA) Y (IIB), EN PRESENCIA DE OR, ZOR EN UNA BASE AUXILIAR TAL COMO BASES CON IMPEDIMENTO ESTERICO, SALES METALICAS DE 1-METILPIPERAZINA (PARA EL COMPUESTO IA), 1-ETILPIPERAZINA (PARA EL COMPUESTO IB), HIDRURO METALICO, OXIDO METALICO, ENTRE OTROS; DONDE R ES CH2CH3 (PARA EL COMPUESTO IA) Y CH2CH2CH3 (PARA EL COMPUESTO IB); ZOR ES UNA SAL DE OR Y Z UN CATION, X ES UN GRUPO SALIENTE TAL COMO ARILSULFONILOXI, (ALQUIL C1-C4)SULFONILOXI, BENCENOSULFONILOXI, ENTRE OTROS. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE TAL COMO ETANOL (PARA EL COMPUESTO IA), n-PROPANOL (PARA EL COMPUESTO IB), ALCANOL C4-C12, CICLOALCANOL C3-C12, ENTRE OTROS) O UNA MEZCLA DE AMBOS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE PRODUCTOS INTERMEDIOS. EL COMPUESTO IA ES UTIL PARA EL TRATAMIENTO DE DISFUNCION DE LA ERECCION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9822238.3A GB9822238D0 (en) | 1998-10-12 | 1998-10-12 | Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001086A1 true PE20001086A1 (es) | 2000-10-18 |
Family
ID=10840421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001016A PE20001086A1 (es) | 1998-10-12 | 1999-10-07 | Procedimiento para la preparacion de pirazolo [4,3-d] pirimidin-7-onas y sus intermedios |
Country Status (49)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000078760A1 (fr) * | 1999-06-21 | 2000-12-28 | The Biochemical Pharmaceutical Factory Of Zhuhai Sez | Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine |
| ATE272626T1 (de) * | 2000-06-22 | 2004-08-15 | Pfizer | Verfahren zur herstellung von pyrazolopyrimidinonen |
| US6667398B2 (en) | 2000-06-22 | 2003-12-23 | Pfizer Inc | Process for the preparation of pyrazolopyrimidinones |
| EP1176142A1 (en) * | 2000-07-28 | 2002-01-30 | Pfizer Inc. | Process for the preparation of pyrazoles |
| EP1176147A1 (en) * | 2000-07-28 | 2002-01-30 | Pfizer Limited | Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| US6407259B1 (en) | 2000-07-28 | 2002-06-18 | Pfizer Inc. | Process for the preparation of pyrazoles |
| PE20020394A1 (es) | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
| WO2003053923A2 (en) * | 2001-12-20 | 2003-07-03 | Applied Research Systems Ars Holding N.V. | Pyrrolidine derivatives as prostaglandin modulators |
| AU2002367023A1 (en) * | 2001-12-21 | 2003-07-30 | Cytokinetics, Inc. | Compositions and methods for treating heart failure |
| SI1509525T1 (sl) | 2002-05-31 | 2006-12-31 | Schering Corp | Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev |
| WO2004072079A1 (en) * | 2003-02-11 | 2004-08-26 | Pfizer Limited | Hydrated and anhydrous sildenafil hemi-citrate compound |
| ATE524452T1 (de) * | 2003-03-27 | 2011-09-15 | Cytokinetics Inc | Sulfonamide zur behandlung von kongestivem herzversagen, deren zusammensetzungen und verwendungen. |
| CN100360531C (zh) * | 2003-12-18 | 2008-01-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物 |
| US20070010525A1 (en) * | 2005-06-27 | 2007-01-11 | Meyer Jackson | Method and compositions for modulating neuropeptide hormone secretion |
| NL2000291C2 (nl) * | 2005-11-10 | 2009-02-17 | Pfizer Prod Inc | 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan. |
| EP2024369A4 (en) * | 2006-06-05 | 2010-10-27 | Matrix Lab Ltd | NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE |
| CZ308056B6 (cs) * | 2015-07-20 | 2019-11-27 | Ustav Experimentalni Botaniky Av Cr V V I | 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
| CN107759603B (zh) * | 2016-08-18 | 2020-09-01 | 四川科伦药物研究院有限公司 | 一种杂环化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
| GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
| GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
| NZ338075A (en) * | 1997-04-25 | 2000-10-27 | Pfizer Ltd | Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PED5) for the treatment of sexual dysfunction |
-
1998
- 1998-10-12 GB GBGB9822238.3A patent/GB9822238D0/en not_active Ceased
-
1999
- 1999-09-22 TW TW088116306A patent/TW589314B/zh not_active IP Right Cessation
- 1999-09-22 CU CU1999142A patent/CU22928A3/es unknown
- 1999-09-27 RS YUP-489/99A patent/RS49762B/sr unknown
- 1999-10-05 GT GT199900172A patent/GT199900172A/es unknown
- 1999-10-06 CZ CZ0353299A patent/CZ296816B6/cs not_active IP Right Cessation
- 1999-10-07 IL IL15292399A patent/IL152923A/en not_active IP Right Cessation
- 1999-10-07 IL IL15292699A patent/IL152926A/en not_active IP Right Cessation
- 1999-10-07 IL IL15292799A patent/IL152927A/en not_active IP Right Cessation
- 1999-10-07 PE PE1999001016A patent/PE20001086A1/es not_active Application Discontinuation
- 1999-10-07 CR CR6118A patent/CR6118A/es unknown
- 1999-10-07 IL IL152928A patent/IL152928A/en not_active IP Right Cessation
- 1999-10-07 AP APAP/P/1999/001672A patent/AP1233A/en active
- 1999-10-07 IL IL15292499A patent/IL152924A/en not_active IP Right Cessation
- 1999-10-07 IL IL13227399A patent/IL132273A/en not_active IP Right Cessation
- 1999-10-08 MY MYPI99004353A patent/MY124620A/en unknown
- 1999-10-08 OA OA9900224A patent/OA11165A/en unknown
- 1999-10-08 US US09/415,440 patent/US6207829B1/en not_active Expired - Fee Related
- 1999-10-08 SK SK1385-99A patent/SK285215B6/sk not_active IP Right Cessation
- 1999-10-08 UA UA99105491A patent/UA66787C2/xx unknown
- 1999-10-08 IS IS5209A patent/IS1951B/is unknown
- 1999-10-08 AR ARP990105109A patent/AR019244A1/es active IP Right Grant
- 1999-10-08 CA CA002285733A patent/CA2285733C/en not_active Expired - Lifetime
- 1999-10-09 CN CNB991239180A patent/CN1207295C/zh not_active Expired - Fee Related
- 1999-10-09 CN CNA031427383A patent/CN1473831A/zh active Pending
- 1999-10-11 DZ DZ990212A patent/DZ2912A1/xx active
- 1999-10-11 ES ES99307996T patent/ES2237049T3/es not_active Expired - Lifetime
- 1999-10-11 EG EG126999A patent/EG22630A/xx active
- 1999-10-11 BR BR9905092-7A patent/BR9905092A/pt not_active IP Right Cessation
- 1999-10-11 ZA ZA9906412A patent/ZA996412B/xx unknown
- 1999-10-11 MA MA25812A patent/MA25007A1/fr unknown
- 1999-10-11 SI SI9930773T patent/SI0994115T1/xx unknown
- 1999-10-11 TN TNTNSN99189A patent/TNSN99189A1/fr unknown
- 1999-10-11 ID IDP990941A patent/ID23351A/id unknown
- 1999-10-11 PT PT99307996T patent/PT994115E/pt unknown
- 1999-10-11 AT AT99307996T patent/ATE290003T1/de active
- 1999-10-11 DK DK99307996T patent/DK0994115T3/da active
- 1999-10-11 NO NO19994943A patent/NO313700B1/no not_active IP Right Cessation
- 1999-10-11 HU HU9903469A patent/HU226162B1/hu not_active IP Right Cessation
- 1999-10-11 EA EA199900822A patent/EA003774B1/ru not_active IP Right Cessation
- 1999-10-11 BG BG103794A patent/BG63205B1/bg unknown
- 1999-10-11 AU AU53581/99A patent/AU756463B2/en not_active Ceased
- 1999-10-11 DE DE69923906T patent/DE69923906T2/de not_active Expired - Lifetime
- 1999-10-11 KR KR10-1999-0043836A patent/KR100380954B1/ko not_active IP Right Cessation
- 1999-10-11 EP EP99307996A patent/EP0994115B1/en not_active Expired - Lifetime
- 1999-10-12 PL PL335959A patent/PL198150B1/pl not_active IP Right Cessation
- 1999-10-12 CO CO99064776A patent/CO5150214A1/es unknown
- 1999-10-12 HR HR990318A patent/HRP990318B1/xx not_active IP Right Cessation
- 1999-10-12 TR TR1999/02541A patent/TR199902541A2/xx unknown
- 1999-10-12 GE GEAP19995027A patent/GEP20022700B/en unknown
- 1999-10-12 UY UY25750A patent/UY25750A1/es not_active Application Discontinuation
- 1999-10-12 JP JP29009999A patent/JP3721021B2/ja not_active Expired - Fee Related
- 1999-10-12 EE EEP199900507A patent/EE04192B1/xx not_active IP Right Cessation
- 1999-10-12 SG SG1999005097A patent/SG118060A1/en unknown
-
2000
- 2000-10-10 HK HK00106399A patent/HK1027559A1/xx not_active IP Right Cessation
-
2001
- 2001-01-16 US US09/761,376 patent/US20010009962A1/en not_active Abandoned
-
2002
- 2002-09-23 US US10/253,029 patent/US20030069422A1/en not_active Abandoned
- 2002-11-18 IL IL15292602A patent/IL152926A0/xx unknown
- 2002-11-18 IL IL15292802A patent/IL152928A0/xx active IP Right Grant
- 2002-11-18 IL IL15292402A patent/IL152924A0/xx unknown
- 2002-11-18 IL IL15292702A patent/IL152927A0/xx unknown
- 2002-11-18 IL IL15292302A patent/IL152923A0/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001086A1 (es) | Procedimiento para la preparacion de pirazolo [4,3-d] pirimidin-7-onas y sus intermedios | |
| RS49653B (sr) | Postupak za dobijanje sildenafila | |
| Stamm | Nucleophilic ring opening of aziridines | |
| PE68699A1 (es) | Pirazolopirimidonas para disfuncion sexual | |
| AU577362B2 (en) | Alpha-halo-ketals and preparation of optically active alpha-arylalkanoic acids | |
| AU533295B2 (en) | Triazolo (4,3-a)pyridines | |
| RS20050340A (en) | Indoles useful in the treatmnet of androgen-receptor related diseases | |
| US10800787B2 (en) | Process for the preparation of acalabrutinib | |
| Yu et al. | A convenient synthesis of 3-polyfluoroalkyl pyrazoles and 6-polyfluoroalkyl pyrimidines from β-polyfluoroalkyl enaminones | |
| Wu et al. | Photocatalytic coupling of electron-deficient alkenes using oxalic acid as a traceless linchpin | |
| AR043273A1 (es) | Derivados de bifenilo, su uso, un proceso para prepararlos y medicamentos que los contienen. | |
| EA200600214A1 (ru) | Арилконденсированные 3-арилпиридиновые соединения и их применение для борьбы с патогенными грибами | |
| ES524642A0 (es) | Un procedimiento para preparar 5-(alquilo inferior)-1,6-naftiridin-2(1h)-onas. | |
| AU3445100A (en) | Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists | |
| HUT58092A (en) | Process for the production of ergolyne derivatives | |
| AR009311A1 (es) | Procedimiento para la preparacion de carbamato de fisostigmina a partir de eteres de eserolina y procedimiento de obtencion de un intermediario en dichoprocedimiento | |
| GB2341799B (en) | Medicaments for the treatment of primary headache disorders and drug-induced headaches | |
| Olah et al. | Considered synthetic methods and reactions. Part 165. One-step preparation of hydrazinium nitrates from tertiary amines and azaarenes with hydroxylamine-O-sulfonic acid/barium nitrate/barium oxide and conversion to energetic amine-nitroimides | |
| Ochiai et al. | Tandem Michael addition–carbene insertion reaction of 1-alkynyl (aryl)(tetrafluoroborato)-λ 3-bromanes: 1-(phenylsulfonyl)-and 1-(trifluoromethylsulfonyl) cyclopentene annulation | |
| RU2021110378A (ru) | Новые растворимые активаторы гуанилатциклазы и ингибиторы фосфодиэстеразы двойного действия и их применение | |
| GB1583997A (en) | Preparation of diaryl-alkylamines | |
| 김태훈 | Excited-State Transition Metal-Catalyzed C–N and C–S Bond Formations | |
| SE326189B (es) | ||
| CO4750712A1 (es) | Adicion organometalica a cetonas | |
| ES2149787T3 (es) | Procedimiento para la obtencion de 2-amino-5-metil-piridina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |